This title appears in the Scientific Report :
2017
Please use the identifier:
http://dx.doi.org/10.1515/hsz-2016-0153 in citations.
Please use the identifier: http://hdl.handle.net/2128/18372 in citations.
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay
Early diagnostics at the preclinical stage of Alzheimer’s disease is of utmost importance for drug development in clinical trials and prognostic guidance. Since soluble Aβ oligomers are considered to play a crucial role in the disease pathogenesis, several methods aim to quantify Aβ oligomers in bod...
Saved in:
Personal Name(s): | Kravchenko, Kateryna |
---|---|
Kulawik, Andreas / Hülsemann, Maren / Kühbach, Katja / Zafiu, Christian / Herrmann, Yvonne / Linnartz, Christina / Peters, Luriano / Bujnicki, Tuyen / Willbold, Johannes / Bannach, Oliver / Willbold, Dieter (Corresponding author) | |
Contributing Institute: |
Strukturbiochemie; ICS-6 |
Published in: | Biological chemistry, 398 (2017) 4, S. 465–475 |
Imprint: |
Berlin [u.a.]
de Gruyter
2017
|
PubMed ID: |
27811340 |
DOI: |
10.1515/hsz-2016-0153 |
Document Type: |
Journal Article |
Research Program: |
Physical Basis of Diseases |
Link: |
OpenAccess OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://hdl.handle.net/2128/18372 in citations.
LEADER | 06917nam a2201045 a 4500 | ||
---|---|---|---|
001 | 823892 | ||
005 | 20210129224859.0 | ||
024 | 7 | |a 10.1515/hsz-2016-0153 |2 doi | |
024 | 7 | |a 1431-6730 |2 ISSN | |
024 | 7 | |a 1437-4315 |2 ISSN | |
024 | 7 | |a WOS:000397610800005 |2 WOS | |
024 | 7 | |a 2128/18372 |2 Handle | |
024 | 7 | |a altmetric:13527416 |2 altmetric | |
024 | 7 | |a pmid:27811340 |2 pmid | |
037 | |a FZJ-2016-06524 | ||
082 | |a 540 | ||
100 | 1 | |a Kravchenko, Kateryna |0 P:(DE-Juel1)136806 |b 0 | |
245 | |a Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay | ||
260 | |a Berlin [u.a.] |c 2017 |b de Gruyter | ||
520 | |a Early diagnostics at the preclinical stage of Alzheimer’s disease is of utmost importance for drug development in clinical trials and prognostic guidance. Since soluble Aβ oligomers are considered to play a crucial role in the disease pathogenesis, several methods aim to quantify Aβ oligomers in body fluids such as cerebrospinal fluid (CSF) and blood plasma. The highly specific and sensitive method surface-based fluorescence intensity distribution analysis (sFIDA) has successfully been established for oligomer quantitation in CSF samples. In our study, we explored the sFIDA method for quantitative measurements of synthetic Aβ particles in blood plasma. For this purpose, EDTA, citrate and heparin treated blood plasma samples from five individual donors were spiked with Aβ coated silica nanoparticles (Aβ-SiNaPs) and were applied to the sFIDA assay. Based on the assay parameters linearity, coefficient of variation and limit of detection, we found that EDTA plasma yields the most suitable parameter values for quantitation of Aβ oligomers in sFIDA assay with a limit of detection of 16 fM. | ||
588 | |a Dataset connected to CrossRef | ||
700 | 1 | |a Kulawik, Andreas |0 P:(DE-Juel1)162310 |b 1 |u fzj | |
700 | 1 | |a Hülsemann, Maren |0 P:(DE-Juel1)145968 |b 2 | |
700 | 1 | |a Kühbach, Katja |0 P:(DE-Juel1)145440 |b 3 |u fzj | |
700 | 1 | |a Zafiu, Christian |0 P:(DE-Juel1)162137 |b 4 |u fzj | |
700 | 1 | |a Herrmann, Yvonne |0 P:(DE-Juel1)159122 |b 5 |u fzj | |
700 | 1 | |a Linnartz, Christina |0 P:(DE-Juel1)145159 |b 6 |u fzj | |
700 | 1 | |a Peters, Luriano |0 P:(DE-Juel1)145123 |b 7 |u fzj | |
700 | 1 | |a Bujnicki, Tuyen |0 P:(DE-Juel1)162212 |b 8 |u fzj | |
700 | 1 | |a Willbold, Johannes |0 P:(DE-Juel1)159192 |b 9 |u fzj | |
700 | 1 | |a Bannach, Oliver |0 P:(DE-Juel1)157832 |b 10 |u fzj | |
700 | 1 | |a Willbold, Dieter |0 P:(DE-Juel1)132029 |b 11 |e Corresponding author |u fzj | |
773 | |a 10.1515/hsz-2016-0153 |g Vol. 0, no. 0 |0 PERI:(DE-600)1466062-3 |n 4 |p 465–475 |t Biological chemistry |v 398 |y 2017 |x 1437-4315 | ||
856 | 4 | |y OpenAccess |u http://juser.fz-juelich.de/record/823892/files/Analysis%20of%20anticoagulants%20for%20blood-based%20quantitation%20of%20amyloid%20%CE%B2%20oligomers%20in%20the%20sFIDA%20assay_2016.pdf | |
856 | 4 | |y OpenAccess |x pdfa |u http://juser.fz-juelich.de/record/823892/files/Analysis%20of%20anticoagulants%20for%20blood-based%20quantitation%20of%20amyloid%20%CE%B2%20oligomers%20in%20the%20sFIDA%20assay_2016.pdf?subformat=pdfa | |
909 | C | O | |o oai:juser.fz-juelich.de:823892 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)162310 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)145440 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)162137 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 5 |6 P:(DE-Juel1)159122 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 6 |6 P:(DE-Juel1)145159 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)145123 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 8 |6 P:(DE-Juel1)162212 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 9 |6 P:(DE-Juel1)159192 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 10 |6 P:(DE-Juel1)157832 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 11 |6 P:(DE-Juel1)132029 | |
913 | 1 | |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-553 |2 G:(DE-HGF)POF3-500 |v Physical Basis of Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 | |
914 | 1 | |y 2017 | |
915 | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search | ||
915 | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BIOL CHEM : 2015 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection | ||
915 | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index | ||
915 | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded | ||
915 | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID | ||
915 | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID | ||
915 | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline | ||
915 | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List | ||
980 | 1 | |a FullTexts | |
980 | |a journal | ||
980 | |a VDB | ||
980 | |a UNRESTRICTED | ||
980 | |a I:(DE-Juel1)ICS-6-20110106 | ||
536 | |a Physical Basis of Diseases |0 G:(DE-HGF)POF3-553 |c POF3-553 |f POF III |x 0 | ||
336 | |a ARTICLE |2 BibTeX | ||
336 | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1490772506_2451 |2 PUB:(DE-HGF) | ||
336 | |a Output Types/Journal article |2 DataCite | ||
336 | |a article |2 DRIVER | ||
336 | |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0) |0 0 |2 EndNote | ||
336 | |a JOURNAL_ARTICLE |2 ORCID | ||
981 | |a I:(DE-Juel1)IBI-7-20200312 | ||
920 | |l yes | ||
920 | |k Strukturbiochemie; ICS-6 |0 I:(DE-Juel1)ICS-6-20110106 |l Strukturbiochemie |x 0 | ||
991 | |a Willbold, Johannes |0 P:(DE-Juel1)159192 |b 9 |u fzj | ||
991 | |a Bujnicki, Tuyen |0 P:(DE-Juel1)162212 |b 8 |u fzj | ||
991 | |a Peters, Luriano |0 P:(DE-Juel1)145123 |b 7 |u fzj | ||
991 | |a Hoffmann, Christina |0 P:(DE-Juel1)145159 |b 6 |u fzj | ||
990 | |a Kravchenko, Kateryna |0 P:(DE-Juel1)136806 |b 0 | ||
991 | |a Willbold, Dieter |0 P:(DE-Juel1)132029 |b 11 |e Corresponding author |u fzj | ||
991 | |a Herrmann, Yvonne |0 P:(DE-Juel1)159122 |b 5 |u fzj | ||
991 | |a Bannach, Oliver |0 P:(DE-Juel1)157832 |b 10 |u fzj | ||
991 | |a Zafiu, Christian |0 P:(DE-Juel1)162137 |b 4 |u fzj | ||
991 | |a Kühbach, Katja |0 P:(DE-Juel1)145440 |b 3 |u fzj | ||
991 | |a Hülsemann, Maren |0 P:(DE-Juel1)145968 |b 2 | ||
991 | |a Kulawik, Andreas |0 P:(DE-Juel1)162310 |b 1 |u fzj |